![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 21, 2008.
Revised June 25, 2008.
Accepted for publication June 25, 2008.
Adenosine is formed in injured/ischemic tissues where it suppresses the actions of essentially all cells of the immune system. Most of the anti-inflammatory actions of adenosine have been attributed to signaling through the Gs protein-coupled A2A adenosine receptor (AR). Here, we report that the A3AR is highly expressed in murine neutrophils isolated from bone marrow. Selective activation of the A3AR with CP-532,903 potently inhibited mouse bone marrow neutrophil superoxide generation and chemotaxis induced by various activating agents. The selectivity of CP-532,903 was confirmed in assays using neutrophils obtained from A2AAR and A3AR gene "knock-out" mice. In a model of thioglycollate-induced inflammation, treating mice with CP-532,903 inhibited recruitment of leukocytes into the peritoneum by specifically activating the A3AR. Collectively, our findings support the theory that the A3AR contributes to the anti-inflammatory actions of adenosine on neutrophils, and provide a potential mechanistic explanation for the efficacy of A3AR agonists in animal models of inflammation, i.e., inhibition of neutrophil-mediated tissue injury.
Key words:
Adenosine, Leukocytes/Mast cells